TWMP
BPMC

Taylor Wealth Management Partners’s Blueprint Medicines BPMC Stock Holding History

Taylor Wealth Management Partners’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-56
Closed -$1K – 142
2015
Q3 		$1K Buy
+56
New +$1.55K ﹤0.01% 151

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Taylor Wealth Management Partners's BPMC Position: Q4 2015 in Review

Taylor Wealth Management Partners sold out of Blueprint Medicines (BPMC) in Q4 2015, closing a stake of 56 shares — an estimated $1K sold.

Taylor Wealth Management Partners first reported a position in BPMC in Q3 2015 and held it in 1 quarter. The position peaked at $1K in Q3 2015. 73 funds tracked by Wall St. Rank hold BPMC as of Q4 2015.

  • Taylor Wealth Management Partners reported no remaining Blueprint Medicines position as of Q4 2015 after selling out during the quarter.
  • Taylor Wealth Management Partners sold 56 Blueprint Medicines shares in Q4 2015, an estimated $1K.
  • Taylor Wealth Management Partners first reported a position in Blueprint Medicines in Q3 2015 and held it in 1 quarter.
  • Taylor Wealth Management Partners's Blueprint Medicines position peaked at $1K in Q3 2015.
  • 73 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2015.

Based on Taylor Wealth Management Partners's 13F filing for Q4 2015, filed 7 Jan 2016.